SG149876A1 - Novel tiotropium salts, methods for the production thereof, and pharmaceutical formulations containing the same - Google Patents
Novel tiotropium salts, methods for the production thereof, and pharmaceutical formulations containing the sameInfo
- Publication number
- SG149876A1 SG149876A1 SG200900492-0A SG2009004920A SG149876A1 SG 149876 A1 SG149876 A1 SG 149876A1 SG 2009004920 A SG2009004920 A SG 2009004920A SG 149876 A1 SG149876 A1 SG 149876A1
- Authority
- SG
- Singapore
- Prior art keywords
- methods
- pharmaceutical formulations
- formulations containing
- production
- same
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
- C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
- C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
- C07D451/06—Oxygen atoms
- C07D451/10—Oxygen atoms acylated by aliphatic or araliphatic carboxylic acids, e.g. atropine, scopolamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pulmonology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Emergency Medicine (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP03025076 | 2003-11-03 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG149876A1 true SG149876A1 (en) | 2009-02-27 |
Family
ID=34530661
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG200900492-0A SG149876A1 (en) | 2003-11-03 | 2004-10-29 | Novel tiotropium salts, methods for the production thereof, and pharmaceutical formulations containing the same |
Country Status (29)
| Country | Link |
|---|---|
| US (1) | US20050096341A1 (es) |
| EP (5) | EP2083007B1 (es) |
| JP (1) | JP5165245B2 (es) |
| KR (1) | KR20060102561A (es) |
| CN (3) | CN1875020B (es) |
| AR (1) | AR046318A1 (es) |
| AT (1) | ATE478071T1 (es) |
| AU (1) | AU2004285685B2 (es) |
| CA (1) | CA2544357A1 (es) |
| CO (1) | CO5690554A2 (es) |
| DE (1) | DE502004011562D1 (es) |
| DK (2) | DK1682543T3 (es) |
| EA (1) | EA012369B1 (es) |
| EC (2) | ECSP066544A (es) |
| ES (2) | ES2422730T3 (es) |
| HK (1) | HK1099753A1 (es) |
| IL (1) | IL175127A (es) |
| MY (1) | MY145166A (es) |
| NO (1) | NO20061441L (es) |
| NZ (1) | NZ547523A (es) |
| PE (1) | PE20050485A1 (es) |
| PL (1) | PL2083007T3 (es) |
| RS (1) | RS20060293A (es) |
| SG (1) | SG149876A1 (es) |
| TW (1) | TW200523263A (es) |
| UA (1) | UA82414C2 (es) |
| UY (1) | UY28589A1 (es) |
| WO (1) | WO2005042528A1 (es) |
| ZA (1) | ZA200602343B (es) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SG137859A1 (en) * | 2003-11-03 | 2007-12-28 | Boehringer Ingelheim Int | Method for producing tiotropium salts, tiotropium salts and pharmaceutical formulations, containing the same |
| JP5315048B2 (ja) * | 2005-06-15 | 2013-10-16 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | 新規チオトロピウム塩の製造方法、新規チオトロピウム塩及びその医薬組成物 |
| WO2006134022A1 (en) * | 2005-06-17 | 2006-12-21 | Boehringer Ingelheim International Gmbh | Mrp iv inhibitors for the treatment of respiratory diseases |
| DE102005035112A1 (de) * | 2005-07-27 | 2007-02-15 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Neues Verfahren zur Herstellung von Tiotropiumsalzen unter Anwendung von in organischen Lösungsmitteln löslichen N-Methylscopiniumsalzen |
| PL2123650T3 (pl) * | 2005-12-19 | 2012-09-28 | Sicor Inc | Nowa postać bromku tiotropium i sposób jej wytwarzania |
| EP1966196A2 (en) * | 2005-12-19 | 2008-09-10 | Sicor, Inc. | Pure and stable tiotropium bromide |
| US20070167480A1 (en) * | 2005-12-19 | 2007-07-19 | Sicor Inc. | Pure and stable tiotropium bromide |
| US9108962B2 (en) | 2005-12-19 | 2015-08-18 | Sicor, Inc. | Forms of tiotropium bromide and processes for preparation thereof |
| US20080051582A1 (en) * | 2006-07-10 | 2008-02-28 | Sicor Inc. | Process for the preparation of tiotropium bromide |
| EP1925295A1 (de) * | 2006-11-22 | 2008-05-28 | Boehringer Ingelheim Pharma GmbH & Co. KG | Stabile Pulverformulierung enthaltend ein Anticholinergikum |
| WO2008089852A1 (de) * | 2007-01-26 | 2008-07-31 | Boehringer Ingelheim Pharma Gmbh & Co.Kg | Neues verfahren zur herstellung von tiotropiumsalzen |
| EP1953156A1 (de) * | 2007-01-29 | 2008-08-06 | Boehringer Ingelheim Pharma GmbH & Co. KG | Verfahren zur Herstellung von Scopiniumsalzen |
| WO2010110760A1 (en) * | 2009-03-27 | 2010-09-30 | Mahmut Bilgic | Compositions comprising water with deuterium for the prevention or treatment of allergic diseases and a process for the preparation thereof |
| PL388070A1 (pl) * | 2009-05-19 | 2010-11-22 | Adamed Spółka Z Ograniczoną Odpowiedzialnością | Nowe sole tiotropium |
| CZ201241A3 (cs) * | 2012-01-20 | 2013-07-31 | Zentiva, K.S. | Nové polymorfní formy tiotropium jodidu a zpusob jejich prípravy |
| WO2013127738A1 (de) * | 2012-02-28 | 2013-09-06 | Boehringer Ingelheim International Gmbh | Neue treibgashaltige tiotropium-formulierung |
Family Cites Families (40)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2597329A (en) * | 1947-08-06 | 1952-05-20 | Merck & Co Inc | Process for anion exchange of thiamin salts |
| US3551492A (en) * | 1967-10-31 | 1970-12-29 | Ciba Geigy Corp | N,n'-diaminoalkoxy-benzyl-diamino-alkanes and the salts thereof |
| US4570630A (en) | 1983-08-03 | 1986-02-18 | Miles Laboratories, Inc. | Medicament inhalation device |
| CA1272917A (en) | 1985-07-30 | 1990-08-21 | Paul Kenneth Rand | Devices for administering medicaments to patients |
| US5610163A (en) * | 1989-09-16 | 1997-03-11 | Boehringer Ingelheim Gmbh | Esters of thienyl carboxylic acids and amino alcohols and their quaternization products |
| DE3931041C2 (de) * | 1989-09-16 | 2000-04-06 | Boehringer Ingelheim Kg | Ester von Thienylcarbonsäuren mit Aminoalkoholen, ihre Quaternierungsprodukte, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel |
| DE4318455A1 (de) | 1993-06-03 | 1994-12-08 | Boehringer Ingelheim Kg | Kapselhalterung |
| DE19536902A1 (de) | 1995-10-04 | 1997-04-10 | Boehringer Ingelheim Int | Vorrichtung zur Hochdruckerzeugung in einem Fluid in Miniaturausführung |
| JP4023086B2 (ja) * | 1999-12-27 | 2007-12-19 | 和光純薬工業株式会社 | スルホニウム塩化合物 |
| MEP40008A (en) * | 2000-10-12 | 2011-02-10 | Boehringer Ingelheim Pharma | Crystalline monohydrate, method for producing the same and the use thereof in the production of a medicament |
| US6908928B2 (en) * | 2000-10-12 | 2005-06-21 | Bi Pharma Kg. | Crystalline tiotropium bromide monohydrate, processes for the preparation thereof, and pharmaceutical compositions |
| UA75375C2 (en) | 2000-10-12 | 2006-04-17 | Boehringer Ingelheim Pharma | Method for producing powdery preparations for inhaling |
| WO2002030389A1 (de) * | 2000-10-12 | 2002-04-18 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Neue tiotropium-haltige inhalationspulver |
| US20020193393A1 (en) * | 2001-03-07 | 2002-12-19 | Michel Pairet | Pharmaceutical compositions based on anticholinergics and PDE-IV inhibitors |
| US20020111363A1 (en) * | 2000-10-31 | 2002-08-15 | Karin Drechsel | Inhalable formulation of a solution containing a tiotropium salt |
| US20020183292A1 (en) * | 2000-10-31 | 2002-12-05 | Michel Pairet | Pharmaceutical compositions based on anticholinergics and corticosteroids |
| EP1837021A3 (de) * | 2000-10-31 | 2008-03-19 | Boehringer Ingelheim Pharma GmbH & Co. KG | Inhalative Lösungsformulierung mit einem Tiotropiumsalz |
| US20020137764A1 (en) * | 2000-10-31 | 2002-09-26 | Karin Drechsel | Inhalable formulation of a solution containing a tiotropium salt |
| US20020193392A1 (en) * | 2000-11-13 | 2002-12-19 | Christel Schmelzer | Pharmaceutical compositions based on tiotropium salts of salts of salmeterol |
| DE10056104A1 (de) * | 2000-11-13 | 2002-05-23 | Boehringer Ingelheim Pharma | Neue Arzneimittelkompositionen auf der Basis von Tiotropiumsalzen und Salzen des Salmeterols |
| DE10061877A1 (de) * | 2000-12-12 | 2002-06-13 | Basf Ag | Verfahren zur Herstellung wässriger Copolymerisatdispersionen von Copolymerisaten aus Kohlenmonoxid und wenigstens einer olefinisch ungesättigten Verbindung |
| DE10064816A1 (de) * | 2000-12-22 | 2002-06-27 | Boehringer Ingelheim Pharma | Verfahren zur Herstellung eines Anticholinergikums |
| US6506900B1 (en) * | 2001-01-31 | 2003-01-14 | Boehringer Ingelheim Pharma Ag | Process for preparing a scopine ester intermediate |
| DE10111843A1 (de) * | 2001-03-13 | 2002-09-19 | Boehringer Ingelheim Pharma | Verbindungen zur Behandlung von inflammatorischen Erkrankungen |
| US20020193394A1 (en) * | 2001-03-13 | 2002-12-19 | Bernd Disse | Compounds for treating inflammatory diseases |
| US20030070679A1 (en) * | 2001-06-01 | 2003-04-17 | Boehringer Ingelheim Pharma Kg | Capsules containing inhalable tiotropium |
| US6608055B2 (en) * | 2001-06-22 | 2003-08-19 | Boehringer Ingelheim Pharma Kg | Crystalline anticholinergic, processes for preparing it and its use for preparing a pharmaceutical composition |
| US6919325B2 (en) * | 2001-09-14 | 2005-07-19 | Boehringer Ingelheim Pharma Kg | Pharmaceutical compositions containing tiotropium salts and low-solubility salmeterol salts |
| DE10200943A1 (de) * | 2002-01-12 | 2003-07-24 | Boehringer Ingelheim Pharma | Verfahren zur Herstellung von Scopinestern |
| US20030229227A1 (en) * | 2002-03-16 | 2003-12-11 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | New difurylglycolic acid esters, processes for the preparation thereof as well as the use thereof as pharmaceutical compositions |
| DE10212264A1 (de) | 2002-03-20 | 2003-10-02 | Boehringer Ingelheim Pharma | Kristallines Mikronisat, Verfahren zu dessen Herstellung und dessen Verwendung zur Herstellung eines Arzneimittels |
| US20030235538A1 (en) * | 2002-04-09 | 2003-12-25 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Method for the administration of an anticholinergic by inhalation |
| US6908055B2 (en) * | 2003-02-27 | 2005-06-21 | Tandberg Data Asa | System for extracting magnetic recording tape from a tape cartridge for engagement with a take-up reel |
| US20050030040A1 (en) * | 2003-06-27 | 2005-02-10 | Mitch Budniak | Electrical testing device having voice annunciator |
| SG137859A1 (en) * | 2003-11-03 | 2007-12-28 | Boehringer Ingelheim Int | Method for producing tiotropium salts, tiotropium salts and pharmaceutical formulations, containing the same |
| US7968717B2 (en) * | 2003-11-03 | 2011-06-28 | Boehringer Ingelhein International Gmbh | Crystalline anhydrate with anticholinergic efficacy |
| SE0303270L (sv) * | 2003-12-03 | 2005-06-04 | Microdrug Ag | Metod för administration av tiotropium |
| SE0303570L (sv) * | 2003-12-03 | 2005-06-04 | Microdrug Ag | Fukt-känslig medicinsk produkt |
| DE102004041253A1 (de) * | 2004-08-26 | 2006-03-02 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Neues Verfahren zur Herstellung von Tiotropiumsalzen |
| JP5315048B2 (ja) * | 2005-06-15 | 2013-10-16 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | 新規チオトロピウム塩の製造方法、新規チオトロピウム塩及びその医薬組成物 |
-
2004
- 2004-10-29 CN CN2004800325224A patent/CN1875020B/zh active Active
- 2004-10-29 PL PL09157299T patent/PL2083007T3/pl unknown
- 2004-10-29 DK DK04791030.2T patent/DK1682543T3/da active
- 2004-10-29 EP EP09157299.0A patent/EP2083007B1/de active Active
- 2004-10-29 AT AT04791030T patent/ATE478071T1/de active
- 2004-10-29 WO PCT/EP2004/012270 patent/WO2005042528A1/de active Application Filing
- 2004-10-29 AU AU2004285685A patent/AU2004285685B2/en active Active
- 2004-10-29 DK DK09157299.0T patent/DK2083007T3/da active
- 2004-10-29 ES ES09157299T patent/ES2422730T3/es active Active
- 2004-10-29 DE DE502004011562T patent/DE502004011562D1/de active Active
- 2004-10-29 CA CA002544357A patent/CA2544357A1/en not_active Abandoned
- 2004-10-29 PE PE2004001046A patent/PE20050485A1/es not_active IP Right Cessation
- 2004-10-29 CN CN201210447516.1A patent/CN102964344B/zh active Active
- 2004-10-29 CN CN200910165195.4A patent/CN101648950B/zh active Active
- 2004-10-29 US US10/976,688 patent/US20050096341A1/en not_active Abandoned
- 2004-10-29 EP EP10180177A patent/EP2322522A1/de not_active Withdrawn
- 2004-10-29 RS YUP-2006/0293A patent/RS20060293A/sr unknown
- 2004-10-29 UY UY28589A patent/UY28589A1/es not_active Application Discontinuation
- 2004-10-29 SG SG200900492-0A patent/SG149876A1/en unknown
- 2004-10-29 NZ NZ547523A patent/NZ547523A/xx unknown
- 2004-10-29 ES ES04791030T patent/ES2350981T3/es active Active
- 2004-10-29 UA UAA200605765A patent/UA82414C2/uk unknown
- 2004-10-29 KR KR1020067010833A patent/KR20060102561A/ko not_active Application Discontinuation
- 2004-10-29 JP JP2006537209A patent/JP5165245B2/ja active Active
- 2004-10-29 EP EP04791030A patent/EP1682543B1/de active Active
- 2004-10-29 EA EA200600854A patent/EA012369B1/ru not_active IP Right Cessation
- 2004-10-29 EP EP10180198A patent/EP2319844A1/de not_active Withdrawn
- 2004-10-29 EP EP10180191A patent/EP2336127A1/de not_active Withdrawn
- 2004-11-01 MY MYPI20044523A patent/MY145166A/en unknown
- 2004-11-02 TW TW093133400A patent/TW200523263A/zh unknown
- 2004-11-03 AR ARP040104039A patent/AR046318A1/es not_active Application Discontinuation
-
2006
- 2006-03-22 ZA ZA200602343A patent/ZA200602343B/en unknown
- 2006-03-30 NO NO20061441A patent/NO20061441L/no not_active Application Discontinuation
- 2006-04-24 IL IL175127A patent/IL175127A/en active IP Right Grant
- 2006-05-02 CO CO06041175A patent/CO5690554A2/es not_active Application Discontinuation
- 2006-05-03 EC EC2006006544A patent/ECSP066544A/es unknown
- 2006-05-03 EC EC2006006545A patent/ECSP066545A/es unknown
-
2007
- 2007-05-29 HK HK07105630.8A patent/HK1099753A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MY123544A (en) | New inhalable powder containing tiotropium | |
| TW200708513A (en) | Novel crystalline forms of tiotropium bromide | |
| RS20050484A (en) | Powdered medicament for inhalation comprising a tiotropium salt and salmeterol xinafoate | |
| NO20061441L (no) | Nye tiotropiumsalter, metoder for deres fremstilling, og farmasoytiske formuleringer inneholdende disse | |
| MY155912A (en) | New inhalable powder containing tiotropium | |
| WO2006117300A3 (en) | Crystalline forms of tiotropium bromide | |
| CY1114157T1 (el) | Αλατα του τιοτροπιου, μεθοδος για την παραγωγη τους και φαρμακευτικα σκευασματα που τα περιεχουν | |
| MY146628A (en) | Novel crystalline anhydride with anticholinergic effect | |
| ECSP055821A (es) | Nueva formulacion pulverulenta que contiene tiotropio destinado a la inhalación | |
| HUP0400222A2 (hu) | PDE-4 inhibitort és H1 receptor antagonistát tartalmazó kombináció és ennek alkalmazása tüdőbetegségek kezelésére alkalmas gyógyszerkészítmény előállítására | |
| MXPA04002401A (es) | Nuevos medicamentos para inhalacion. | |
| DK1494648T3 (da) | Pulverpræparat til inhalation | |
| WO2005007134A8 (de) | Pulverformulierungen für die inhalation enthaltend ein neues anticholinergikum | |
| CY1113392T1 (el) | Νεες κρυσταλλικες μορφες του βρωμιουχου τιοτροπιου | |
| BRPI0415685A (pt) | sais de tiotrópio, processos para sua produção, bem como formulações de medicamentos contendo os mesmos |